Patent: 5,208,041
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,208,041
Title: | Essentially pure human parathyroid hormone |
Abstract: | Human parathyroid hormone is provided in an ultrapure form characterized by the absence of protein contaminants detectable by capillary electrophoresis analysis. A method for obtaining such ultrapure human parathyroid hormone is also described. |
Inventor(s): | Sindrey; Dennis R. (Etobicoke, CA) |
Assignee: | Allelix Biopharmaceuticals Inc. (Mississauga, CA) Glaxo Canada Inc. (Mississauga, CA) |
Application Number: | 07/707,114 |
Patent Claims: | see list of patent claims |
Details for Patent 5,208,041
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | See Plans and Pricing | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |